Cuscal (CCL) ASX SMIDcaps Conference Presentation summary
Event summary combining transcript, slides, and related documents.
ASX SMIDcaps Conference Presentation summary
8 Oct, 2025Market position and business model
Leading independent B2B payments provider in Australia, serving ADIs, non-ADIs, and fintechs with end-to-end infrastructure and regulated data services.
Does not compete with clients in B2C, focusing on supporting a broad institutional customer base.
Holds all necessary licenses and connectivity for all payment types, with a strong, long-tenured client base.
Well-capitalised with an investment grade rating and a predictable financial model.
Revenue model supported by contracted clients and diversified revenue streams.
Core capabilities and innovation
Provides issuing and acquiring services for debit, credit, and prepaid cards, supporting major card networks and digital wallets.
Processes real-time payments via NPP, supports direct debit, BPAY, and bulk payments.
Track record of innovation, including firsts in ATM, Visa debit, payWave, and digital wallet adoption.
Significant technology investment ($100m+ FY22–FY24) to enhance capabilities and operating leverage.
Acquisitions and new service launches, such as Basiq Group and NPP PayTo, drive growth.
Financial performance and growth
H1 FY25 saw 7% transaction volume growth and earnings growth across all core capabilities.
Improvement in all key financial metrics, including EBITDA, NPAT, EPS, and ROE.
On track to meet or exceed FY25 pro forma NPAT forecast.
Well positioned for further growth and margin expansion due to recent investments and market position.
Latest events from Cuscal
- Profit up 21% to $31.6m, dividend increased, and IPO targeted for late 2024.CCL
H2 202425 Mar 2026 - NPAT up 76%, underlying NPAT up 13%, and FY26 outlook raised after Indue acquisition.CCL
H1 202624 Feb 2026 - Pro forma NPAT up 42% to $21.5m, with 7% transaction volume growth and strong capital.CCL
H1 202511 Oct 2025 - FY25 results beat forecasts; Indue acquisition to deliver major cost synergies and EPS growth.CCL
H2 202511 Oct 2025